Carisma Therapeutics Provides Business Update and Reports Fo

/PRNewswire/ -- Carisma Therapeutics Inc. (NASDAQ: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

Related Keywords

Philadelphia , Pennsylvania , United States , John Hohneker , Steven Kelly , Shveta Dighe , Chidozie Ugwumba , Prnewswire Carisma Therapeutics Inc , Carisma Therapeutics Inc , Moderna Tx Inc , Nasdaq , Company Annual Report On Form , Drug Administration , Sesen Bio Inc , Exchange Commission , Board Of Directors The Company , While The Company , Chief Executive Officer , Pipeline Updates , Upcoming Milestones , Investigational New Drug , Moderna Collaboration , Full Year , Cash Equivalents , Sesen Bio , Private Securities Litigation Reform Act , Annual Report , Convertible Preferred Stock , Stockholder Equity , Carisma Therapeutics ,